ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
ESC Premium Access
MARINER.
Session:
Meet the trialist - MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk
Topic:
Prevention
Speaker:
Professor A. Spyropoulos (New York, US)
Event:
ESC Congress 2018
Congress Presentation
Sign in for access options
Sign in for access options
Sign in for access options
Add to my library
Like
About the speaker
Professor Alex Spyropoulos
Northwell Health, New York (United States of America)
4
presentations
0
follower
Access the full session
Meet the trialist - MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk
Speakers:
Professor A. Spyropoulos
Access
Like
About the event
ESC Congress 2018
25 August - 29 August 2018
Sessions
Presentations
ESC 365 is supported by
Explore sponsored resources
Explore sponsored resources
